Docebo (NASDAQ:DCBO) Price Target Raised to $22.00

Docebo (NASDAQ:DCBO) had its price objective hoisted by equities researchers at National Bank Financial from $21.00 to $22.00 in a report issued on Monday,BayStreet.CA reports. The brokerage presently has a “sector perform” rating on the stock. National Bank Financial’s price target suggests a potential upside of 14.79% from the stock’s previous close.

Several other research firms have also recently issued reports on DCBO. Zacks Research cut shares of Docebo from a “strong-buy” rating to a “hold” rating in a research report on Monday, May 25th. Wall Street Zen downgraded Docebo from a “buy” rating to a “hold” rating in a research report on Sunday, May 17th. Cantor Fitzgerald reissued an “overweight” rating and issued a $28.00 target price on shares of Docebo in a research note on Wednesday, April 22nd. ATB Cormark Capital Markets reduced their target price on shares of Docebo from $36.00 to $35.00 and set an “outperform” rating on the stock in a research note on Monday. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $31.00 price target on shares of Docebo in a research note on Friday. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Docebo presently has an average rating of “Moderate Buy” and an average price target of $31.08.

Docebo Price Performance

Shares of NASDAQ DCBO traded down $1.22 during midday trading on Monday, reaching $19.16. The stock had a trading volume of 98,661 shares, compared to its average volume of 169,666. The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a 50-day moving average of $17.84 and a 200-day moving average of $18.49. The company has a market capitalization of $481.81 million, a price-to-earnings ratio of 16.52 and a beta of 1.27. Docebo has a 12-month low of $14.39 and a 12-month high of $33.42.

Institutional Investors Weigh In On Docebo

A number of institutional investors and hedge funds have recently bought and sold shares of DCBO. Wellington Management Group LLP grew its position in shares of Docebo by 45.1% during the 3rd quarter. Wellington Management Group LLP now owns 432,426 shares of the company’s stock worth $11,818,000 after buying an additional 134,437 shares in the last quarter. Royal Bank of Canada grew its holdings in Docebo by 467.1% during the 1st quarter. Royal Bank of Canada now owns 158,340 shares of the company’s stock worth $4,546,000 after acquiring an additional 130,419 shares in the last quarter. Millennium Management LLC increased its position in Docebo by 137.2% during the 4th quarter. Millennium Management LLC now owns 213,444 shares of the company’s stock valued at $4,741,000 after purchasing an additional 123,473 shares during the period. Two Sigma Investments LP raised its holdings in shares of Docebo by 211.3% in the 3rd quarter. Two Sigma Investments LP now owns 160,772 shares of the company’s stock valued at $4,394,000 after purchasing an additional 109,128 shares in the last quarter. Finally, NewGen Asset Management Ltd purchased a new stake in shares of Docebo in the 1st quarter worth approximately $1,558,000. 53.17% of the stock is owned by institutional investors.

Docebo Company Profile

Docebo is a cloud-based learning management system (LMS) provider that offers enterprise organizations a comprehensive platform for employee, customer and partner training. The company’s software is designed to streamline learning and development with features such as AI-powered content recommendations, automated learning paths and social collaboration tools. Docebo’s platform supports multiple languages and integrates with a variety of third-party applications, enabling businesses to deliver training at scale across different departments and regions.

Founded in 2005 and headquartered in Toronto, Canada, Docebo has expanded its footprint to serve customers in North America, Europe, the Middle East and the Asia Pacific region.